The Fourth Bioelectronic Medicine Summit “Technology Targeting Molecular Mechanisms”: current progress, challenges, and charting the future
Timir Datta, Theodoros P. Zanos, Eric H. Chang, Peder S. Olofsson, Stephan Bickel, Chad Bouton, Daniel A. Grande, Loren Rieth, Cynthia Aranow, Ona Bloom, Ashesh D. Mehta, Gene Civillico, Molly M. Stevens, Eric Daniel Głowacki, Christopher J. Bettinger, Martin Schüettler, Chris Puleo, Robert L. Rennaker, Sarajo K. Mohanta, Daniela Carnevale, Sílvia V. Conde, Bruno Bonaz, David Chernoff, Suraj Kapa, Magnus Berggren, Kip A. Ludwig, Stavros Zanos, Larry S. Miller, Doug Weber, Daniel Yoshor, Lawrence Steinman, Sangeeta S. Chavan, Valentin A. Pavlov, Yousef Al‐Abed, Kevin J. Tracey
Abstract
There is a broad and growing interest in Bioelectronic Medicine, a dynamic field that continues to generate new approaches in disease treatment. The fourth bioelectronic medicine summit "Technology targeting molecular mechanisms" took place on September 23 and 24, 2020. This virtual meeting was hosted by the Feinstein Institutes for Medical Research, Northwell Health. The summit called international attention to Bioelectronic Medicine as a platform for new developments in science, technology, and healthcare. The meeting was an arena for exchanging new ideas and seeding potential collaborations involving teams in academia and industry. The summit provided a forum for leaders in the field to discuss current progress, challenges, and future developments in Bioelectronic Medicine. The main topics discussed at the summit are outlined here.